Diagnostic Radiopharmaceuticals & Contrast Media Market Research Report 2021 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Diagnostic Radiopharmaceuticals & Contrast Media Market: Global Market Size, Forecast, Insights, and Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.

The global diagnostic radiopharmaceuticals & contrast media market is expected to grow at a CAGR of around 3.1% during 2021-2027

This report on global diagnostic radiopharmaceuticals & contrast media market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape.

The report presents a clear picture of the global diagnostic radiopharmaceuticals & contrast media market by segmenting the market based on type, procedure, application, and region.

Also, detailed profiles of companies operating in the diagnostic radiopharmaceuticals & contrast media market are provided in this report.

Market Drivers

• Technological Advancements in the Minimally Invasive Therapeutic Procedures
• Rising Cases of Cancer

Market Challenges

• Stringent Regulatory Framework
• Shorter Half-life of Radiopharmaceuticals

Historical & Forecast Period

• Base Year: 2020
• Historical Period: 2016-2020
• Forecast Period: 2021-2027

Key Topics Covered:

1. Preface

1.1 Objective

1.2 Target Audience & Key Offerings

1.3 Report's Scope

1.4 Research Methodology

1.5 Assumptions

2. Key Insights

3. Global Diagnostic Radiopharmaceuticals & Contrast Media Market

3.1. Introduction

3.2. Market Drivers

3.3. Market Challenges

4. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Analysis

4.1. Market Portraiture

4.2. Market Size

4.3. Market Forecast

4.4. Impact of COVID-19

5. Global Radiopharmaceuticals Market by Type

5.1. Introduction

5.2. SPECT

5.2.1. Tc-99

5.2.2. Tl-201

5.2.3. Ga-67

5.2.4. I-123

5.2.5. Other SPECTs

5.3. PET

5.3.1. F-18

5.3.2. Rb-82

5.3.3. Other PETs

6. Global Radiopharmaceuticals Market by Application

6.1 Introduction

6.2 Diagnostics

6.2.1 Cardiology

6.2.2 Oncology

6.2.3 Neurology

6.2.4 Others

6.3 Therapeutics

6.3.1 Thyroid

6.3.2 Lymphoma

6.3.3 Endocrine Tumors

6.3.4 Others

7. Global Contrast Media Market by Type

7.1 Introduction

7.2 Iodinated Contrast Media

7.3 Gadolinium-based Contrast Media

7.4 Microbubble Contrast Media

7.5 Barium-based Contrast Media

8. Global Contrast Media Market by Procedure

8.1 Introduction

8.2 X-ray/Computed Tomography (CT)

8.3 Magnetic Resonance Imaging (MRI)

8.3 Ultrasound

9. Global Contrast Media Market by Application

9.1 Introduction

9.2 Cardiovascular Disease

9.3 Oncology

9.4 Gastrointestinal Disorders

9.5 Neurological Disorders

9.6 Other Indications

10. Global Diagnostic Radiopharmaceuticals & Contrast Media Market by Region

10.1 Introduction

11. SWOT Analysis

12. Porter's Five Forces

13. Market Value Chain Analysis

14. Competitive Landscape

14.1 Competitive Scenario

14.2 Company Profiles

• Bayer AG
• Bracco Imaging SpA
• Cardinal Health Inc.
• Curium
• GE Healthcare
• Guerbet Group
• Lantheus Holdings Inc.
• Nordion Inc.
• NTP Radioisotopes SOC Ltd
• Siemens Healthineers

For more information about this report visit https://www.researchandmarkets.com/r/28g1eg